Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 12.09.2024       Rath AG

‘Based on a current forecast for 2024, the Executive Board of Rath AG announces a significant decline in EBIT in 2024 compared to the previous year. The significant decrease in EBIT is due to a decline in revenue as a result of lower market demand and cost increases, particularly in wages and salaries.’   End of Inside Information 12-Sep-2024 CET/ [ … ]
Thu, 12.09.2024       LAIQON AG

Company Name: LAIQON AG ISIN: DE000A12UP29   Reason for the research: Update Recommendation: Buy from: 12.09.2024 Target price: €9.80 Target price on sight of: 12 months Last rating change: - Analyst: Christian Orquera First Berlin Equity Research has published a research update on LAIQON AG (ISIN: DE000A12UP29). Analyst Ch [ … ]
Thu, 12.09.2024       LAIQON AG

Company Name: LAIQON AG ISIN: DE000A12UP29   Reason for the research: Update Recommendation: Buy from: 12.09.2024 Target price: €9.80 Target price on sight of: 12 months Last rating change: - Analyst: Christian Orquera First Berlin Equity Research has published a research update on LAIQON AG (ISIN: DE000A12UP29). Analyst Ch [ … ]
Thu, 12.09.2024       Symrise AG

Press release — Holzminden, September 12, 2024 Executive Board of Symrise AG reorganized Walter Ribeiro appointed Board Member for the Taste, Nutrition & Health segment Jörn Andreas leaves Symrise at his own request and on the best of terms Jean-Yves Parisot takes over as interim head of the Scent & Care segment The Supervisory Board of [ … ]
Thu, 12.09.2024       Symrise AG

Press release — Holzminden, September 12, 2024 Executive Board of Symrise AG reorganized Walter Ribeiro appointed Board Member for the Taste, Nutrition & Health segment Jörn Andreas leaves Symrise at his own request and on the best of terms Jean-Yves Parisot takes over as interim head of the Scent & Care segment The Supervisory Board of [ … ]
Thu, 12.09.2024       A2Z Smart Technologies Corp.

TEL AVIV, ISRAEL / ACCESSWIRE / September 12, 2024 / A2Z Cust2Mate Solutions Corp. ("A2Z" or the "Company") (NASDAQ:AZ)(FRA - WKN:A3CSQ), a global leader in innovative technology solutions, is pleased to announce that its subsidiary Cust2Mate Ltd., a leading provider of smart shopping cart solutions, has submitted a patent application for its Shopp [ … ]
Thu, 12.09.2024       A2Z Smart Technologies Corp.

TEL AVIV, ISRAEL / ACCESSWIRE / September 12, 2024 / A2Z Cust2Mate Solutions Corp. ("A2Z" or the "Company") (NASDAQ:AZ)(FRA - WKN:A3CSQ), a global leader in innovative technology solutions, is pleased to announce that its subsidiary Cust2Mate Ltd., a leading provider of smart shopping cart solutions, has submitted a patent application for its Shopp [ … ]
Thu, 12.09.2024       CoinShares Digital Securities Limited

12 September 2024 CoinShares Digital Securities Limited Exchange Traded Products Programme for the issue of CoinShares Digital Securities   LEI: 549300DR7967WVLR3P83   CoinShares Physical Bitcoin and CoinShares Physical Staked Solana - Increase of Issued Digital Securities     Jersey - 12 September 2024 - CoinShares Digital Securities Lim [ … ]
Thu, 12.09.2024       CoinShares Digital Securities Limited

12 September 2024 CoinShares Digital Securities Limited Exchange Traded Products Programme for the issue of CoinShares Digital Securities   LEI: 549300DR7967WVLR3P83   CoinShares Physical Bitcoin and CoinShares Physical Staked Solana - Increase of Issued Digital Securities     Jersey - 12 September 2024 - CoinShares Digital Securities Lim [ … ]
Thu, 12.09.2024       CureVac

CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program   Phase 2 data demonstrated positive immune responses to A and B strains, with acceptable safety and reactogenicity profile, meeting all pre-defined study endpoints  Vaccine candidate based on CureVac’s proprietary second-generation mRNA backbone GSK [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 21.10.2024, Calendar Week 43, 295th day of the year, 71 days remaining until EoY.